時代中國(01233.HK)未能支付2023及2024年到期兩筆優先票據利息
時代中國控股(01233.HK)公布,尚未支付於2023年到期的6.6%優先票據及於2024年到期的5.55%優先票據的有關利息,該等優先票據的寬限期分別於2022年12月30日及2023年1月3日到期。
公司補充,未能支付款項或會導致該兩個系列境外美元計值優先票據持有人要求加快還款,倘發生此情況,則將賦予其他債權人要求加快還款的權利。至今公司未有接獲該兩個系列境外美元計值優先票據持有人有關要求加快還款的任何通知。
由於暫停支付境外美元計值優先票據的款項及應公司要求,境外美元計值優先票據已於今日(5日)上午九時正起暫停買賣,直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.